Profile

Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number of regenerative medicine applications. CelluJuve® is being developed as an extended duration dermal filler for aesthetic soft tissue augmentation. CelluBridge®, Spiderwort’s solution for spinal cord injury repair, has been granted a breakthrough designation by the FDA after promising preclinical results where it supported regenerating axons leading to locomotor recovery. It is extending the CelluBridge® technology to peripheral nerve injury applications and are interested in codeveloping further uses of the biomaterial platform.

Spiderwort Biotechnologies logo

Website

spiderwortbio.com

Contact


Event details

Date: October 5 - 8, 2025

Event contact

Patricia Cosgrove
Area Director
USA: Life Sciences

Participants

14 in total